Mainz Biomed, Quest Diagnostics To Commercialize NextGen Colorectal Cancer Screening Test; Stock Up
(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...
Mainz Biomed forms agreement with Quest Diagnostics
Mainz Biomed (MYNZ) announced an agreement with Quest Diagnostics (DGX), a leading provider of diagnostic information services, to support ...